A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease
一项多中心、随机、双盲、安慰剂对照、递增剂量研究，旨在评估Posiphen在早期阿尔茨海默病患者中的安全性、耐受性、药代动力学(PK)和药效学(PD)效应。
期刊:Alzheimers Research & Therapy
影响因子:7.6
doi:10.1186/s13195-024-01490-z
Galasko, Douglas; Farlow, Martin R; Lucey, Brendan P; Honig, Lawrence S; Elbert, Donald; Bateman, Randall; Momper, Jeremiah; Thomas, Ronald G; Rissman, Robert A; Pa, Judy; Aslanyan, Vahan; Balasubramanian, Archana; West, Tim; Maccecchini, Maria; Feldman, Howard H
